Engineering the Modular Receptor-Binding Proteins of <i>Klebsiella</i> Phages Switches Their Capsule Serotype Specificity
The antimicrobial resistance crisis has rekindled interest in bacteriophage therapy. Phages have been studied over a century as therapeutics to treat bacterial infections, but one of the biggest challenges for the use of phages in therapeutic interventions remains their high specificity.
Guardado en:
Autores principales: | Agnieszka Latka, Sebastien Lemire, Dennis Grimon, Dorien Dams, Barbara Maciejewska, Timothy Lu, Zuzanna Drulis-Kawa, Yves Briers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36e95705b69246a8b345654cdab5e058 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase
por: Agnieszka Latka, et al.
Publicado: (2020) -
The Mutation in <i>wbaP cps</i> Gene Cluster Selected by Phage-Borne Depolymerase Abolishes Capsule Production and Diminishes the Virulence of <i>Klebsiella pneumoniae</i>
por: Marta Kaszowska, et al.
Publicado: (2021) -
Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue
por: Barbara Maciejewska, et al.
Publicado: (2017) -
Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
por: Maarten Walmagh, et al.
Publicado: (2012) -
Isolation and Characterization of Novel Phages Targeting Pathogenic Klebsiella pneumoniae
por: Na Li, et al.
Publicado: (2021)